<DOC>
	<DOCNO>NCT00332826</DOCNO>
	<brief_summary>The clinical trial design evaluate safety inhale Technosphere/Insulin compare non-inhaled anti-diabetic therapy subject type 1 type 2 diabetes mellitus concurrent asthma .</brief_summary>
	<brief_title>Inhaled Technosphere Insulin Subjects With Diabetes Mellitus Asthma</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>A clinical diagnosis Step 1 3 asthma per NAEPP guideline Clinical diagnosis Type 1 Type 2 diabetes mellitus least 1 year Current stable antidiabetic regimen ( insulin alone combination oral antihyperglycemic agent ) Subjects must exhibit &lt; 30 % variability PEF measurement 2 week run period . Subjects must meet criteria exacerbation asthma 2 week run period Body mass index ( BMI ) &lt; 40kg/m2 HbA1c &gt; 6.0 % &lt; 11.5 % Severe complication diabetes opinion investigator Seizure disorder Significant cardiovascular dysfunction and/or history within 3 month screen Hypertension systolic blood pressure ! 80 mm Hg and/or diastolic blood pressure &gt; 110 mm HG screen despite pharmacologic therapy . Clinical nephrotic syndrome renal dysfunction disease Total daily insulin requirement &gt; 1.4 U/kg body weight Clinical diagnosis Step 4 asthma Use &gt; 6 puffs/day fast acting bronchodilator Currently use insulin delivery pump Use Pramlintide acetate incretins must discontinue 8 week prior screen Two severe hypoglycemic episode within past 6 month . Any hospitalization emergency room visit due poor diabetic control 6 month screen . Current use systemic steroid Subjects currently smoke tobacco smoke within past 6 month Urine cotinine test &gt; 100ng/ml Current drug alcohol abuse Clinically significant abnormality screen laboratory evaluation Cancer within past 5 year history lung neoplasms History active and/or cirrhotic hepatic disease and/or abnormal liver enzyme . Active infection history severe infection 30 day screen . Anemia History anaphylaxis and/or angioneurotic edema Diagnosis chronic obstructive pulmonary disease ( COPE ) Previous exposure inhale insulin product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Inhaled insulin</keyword>
	<keyword>Diabetes Type I II Asthma</keyword>
</DOC>